Save the Date for Applied Pharmaceutical Analysis 2019!

September 9-11, 2019

Revere Hotel Boston Common 
200 Stuart Street 
Boston, MA 02116


Proposed Sessions for APA 2019 Workshops 

Discovery Bioanalysis and New Technologies

Novel modalities, guidance for new modalities

Cellular and gene therapies



Protein Degradation

Application of HRMS

AI Session - predict the structure


Flow Cytometry

Reagent Characterization



APA 2018 Conference Program


APA 2018 Plenary Speakers

donna dambach     

Donna Dambach, VMD, PhD, Senior Director, Head of Toxicology, Safety Assessment, Genentech

Translation Insights in Nonclinical Safety Assessment


Binodh DeSilva, PhD, Head of Analytical Strategy & Operations, Product Development, BMS

The Impact of a Reagent Center of Excellence on Bioanalysis, and a Company’s Strategy around Variabilization

Richard Smith APA2018     

Richard Smith, PhD, Batelle Fellow and Director of Proteome Research, Pacific Northwest National Laboratory

New Developments in Ion Mobility-Mass Spectrometry Enabling Higher Throughput and More Sensitive Proteomics and Pan-Omics Measurements for Clinical Diagnostics and Personalized Medicine

Joe Cornicelli  

Joseph Cornicelli, PhD, Senior Director In Vivo Pharmacology, Charles River Laboratories

Research Models for Non-Alcoholic Steatohepatitis: The Need and Challenges for Evaluating Candidate Therapies


APA 2018 Confirmed Speakers

Jonathan Bauman APA2018

Johnathan Bauman, Principal Scientist, Pfizer

Accelerating the Delivery of Small Molecule High Resolution Accurate Mass Structure Elucidation Results Through the Use of Thermo Scientific™ Compound Discoverer Software™


Joseph Camardo, Senior Vice President Celgene Global Health and Global Medical Affairs, Celgene

Attention to Neglected Tropical Diseases: The Impact of the Pharmaceutical Industry and the Mission of Celgene Global Health

Andrea Casasola LaMacchia APA2018

Andrea Casasola-LaMacchia, Postdoctoral Scientist, Pfizer

Quantitative Biomarkers & Biomeasures BioMedicine Design

  Joe Cornicelli

Joseph Cornicelli, Senior Director, In Vivo Pharmacology, Charles River Laboratories

Research Models for NASH

 Arindam Dasgupta  

Arindam Dasgupta, Deputy Director, Division of New Drug Bioequivalence, OSIS, OTS, CDER, FDA

Common BA/BE Inspection Observations and their Mitigation Strategies

   Bill APA photo  

William Gerwick, Distinguished Professor of Oceanography and Pharmaceutical Sciences, Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego

Antiparasitic Drug Discovery from Marine Cyanobacteria

Jochem Gokemeijer

Jochem Gokemeijer, Associate Director, Bristol-Myers Squibb

Title TBA


Sylvia Janetzki, Founder and President, ZellNet Consulting

Monitoring the Function of Single Immune Cells - How to Tackle this Daunting Task and Apply Cutting-Edge Developments for Obtaining Meaningful Data

Vibha Jawa

Vibha, Jawa, Director Biologics and Vaccine Development, Merck

Current Perspectives on Preclinical Predictive Tools for Immunogenicity Risk Assessment and their Clinical Translation

   Sadik Kassim  


Sadik Kassim, CSO, Mustang Bio

CART-ography:  Lessons Learned from the Analytical Characterization of the First Two FDA Approved Chimeric Antigen Receptor Therapies


Kochansky Christopher pict APA2018

Christopher Kochansky, Research Scientist, Merck

Automated Metabolite Identification for Design Ideation

   Ashutosh Kulkarni APA2018

Ashutosh Kulkarni, Director of Clinical Pharmacology, Nonclinical and Translational Sciences Group, Allergan

ADME Screening Paradigm for Covalent Inhibitor Drugs – Role of Traditional vs Non-Traditional Assays

Xiaomin Liang APA2018

Xiaomin Liang, Research Scientist, Drug Metabolism, Gilead

Use of In Vitro Tools and Genetic Data to Identify Transporter Endogenous Biomarkers

   John O Link

John O. Link, Vice President, Medicinal Chemistry, Gilead Sciences 

Drug Discovery in "Rulebreaker" Chemical Space: Ledipasvir and Velpatasvir

Holly Maw

Holly Maw, Scientist IV, Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim Pharmaceuticals

N-methylation of BI 187004 by thiol-S-methyltransferase

   Jun Qu  

Jun Qu, Professor, Department of Pharmaceutical Sciences, SUNY-Buffalo, Chief Scientist in Bioanalysis, New York Center of Excellence in Bioinformatics and Life Sciences

Sensitive and Robust Trapping-Micro-LC-MS for the Quantification of Biomarkers and Antibody Therapeutics

Giovanna Scapin APA2018

Giovanna Scapin, Principal Scientist, Merck

Insights into the Insulin Receptor Activation: the Cryo-EM Structure of the IR in Complex with Insulin

   Keith Sutton Pict APA2018  

Keith Sutton, Senior Research Scientist, Charles River Laboratories, UK

When the Cell is the Drug, Challenges for Bioanalysis

 S Voytek sq  

Sarah Voytek, Associate Director, Preclinical Development, bluebird bio

Drug Distribution Analysis in the Preclinical Development of Gene and Cell Therapy Products

   Debra Luffer Atlas APA2018

Debra Luffer-Atlas, Senior Research Fellow, Eli Lilly

An ADME Perspective on DILI Hazard Identification  

Jing Tao

Jing-Tao Wu, Vice President DMPK and Investigative Toxicology, Alnylam Pharmaceuticals

Mechanistic ADME of siRNA-GaINAc Conjugates

  Yuhong Xiang APA2018  

Yuhong Xiang, Scientist, Pfizer

Development of a Robust Neutralizing Antibody (NAb) Assay with High Drug and Target Tolerance to Support Clinical Development of an anti-TFPI Therapeutic Monoclonal Antibody (mAb)

Ming Yao picture APA2018

Ming Yao, Senior Research Scientist, Bristol-Myers Squibb

Fast and Comprehensive Detection and Characterization of Cyclic Peptide Metabolites using Software-Aided Data Processing Tools





Other confirmed speakers:

Michael F. Skelly, Ph.D., Lead Pharmacologist, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Study Integrity and Surveillance, U.S. Food and Drug Administration

Jianwei Shen, Ph.D., Prinicipal Scientist, AbbVie 

Chuck Gu, Ph.D. Prinicipal Scientist, Biotransformation Group Lead, Biogen

Guowen Liu, Ph.D., Director of Bioanalyis, Agios



Proposed Sessions for APA 2018 Workshops 

Regulated Bioanalysis

Regulatory Session / Guidance

Challenges of Immunotherapy in a Regulated Environment

Bioanalytical Support for Novel Therapies

Miscellaneous Topics in Bioanalysis

New Technologies and Applications

Discovery Bioanalysis and New Technologies

Anti-Drug Antibodies (ADA)

Information Technology - Knowledge Management

New Technologies


Mechanistic ADME

Unusual Metabolites


Speciality Molecules: Going Beyond the Rule of 5

Software for Met ID

Combined Mechanistic Adme and Discovery Bioanalysis

Role of DMPK in New Modalities

Exploratory Biomarker Analysis

Beyond ADME and Bioanalysis



Global Health

Rare/Neglected Diseases

Novel Drug Delivery Systems



 Join our Linkedin Group:


Regulated Bioanalysis


Mechanistic ADME


Click here to register for the APA 2019 conference online.

APA 2019 will take place September 9th-11th, 2019 at:

Revere Hotel Boston Commmon

Boston, MA


The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3


Sign Up Today!

Privacy Policy